Anson Funds Management LP Humanigen, Inc Transaction History

Anson Funds Management LP

  • $839 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$13.54 - $22.74 $9.48 Million - $15.9 Million
-700,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$12.91 - $23.83 $9.04 Million - $16.7 Million
700,000 New
700,000 $13.4 Million
Q4 2020

Feb 16, 2021
SELL
$7.97 - $21.66 $3.25 Million - $8.84 Million
-408,356 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$8.0 - $28.5 $3.27 Million - $11.6 Million
408,356 New
408,356 $4.35 Million

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email